GILD Jun 2024 72.500 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:57AM EDT. Market open.
Loading interactive chart...
- ACCESSWIRE
Gilead Sciences Partners With White House for Early Cancer Detection Program "Biden Cancer Moonshot"
NORTHAMPTON, MA / ACCESSWIRE / May 28, 2024 / Gilead Sciences: In an effort to advance access to cancer prevention and early detection among U.S. workers, the Biden Cancer Moonshot recently announced a series of actions that organizations are taking ...
- Business Wire
Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024
FOSTER CITY, Calif., May 22, 2024--Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research to be presented at the European Association for the Study of the Liver (EASL) Congress, June 5-8, 2024 in Milan, Italy. Key findings from more than 25 abstracts will include:
- Zacks
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.
© 2024 Yahoo. All rights reserved.